Personal information

No personal information available

Activities

Employment (1)

Fondazione IRCCS Istituto Nazionale dei Tumori: Milano, Lombardia, IT

2012-05-21 to present (Medical Oncology)
Employment
Source: Self-asserted source
Paolo Grassi

Education and qualifications (2)

Sapienza Università di Roma: Roma, Lazio, IT

2008 to 2012 | Residency/Medical Oncologist
Education
Source: Self-asserted source
Paolo Grassi

Università degli Studi di Roma La Sapienza Facoltà di Medicina e Odontoiatria: Roma, Lazio, IT

2001-10 to 2007-03 | MD
Education
Source: Self-asserted source
Paolo Grassi

Works (41)

Does F-18 FDG-PET still play a role in metastatic renal cell carcinoma?

Journal of Medical Imaging and Radiation Oncology
2017 | Journal article
EID:

2-s2.0-85017222465

Contributors: Mennitto, A.; Grassi, P.; Verzoni, E.; Ratta, R.; Procopio, G.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Everolimus treatment for neuroendocrine tumors: Latest results and clinical potential

Therapeutic Advances in Medical Oncology
2017 | Journal article
EID:

2-s2.0-85014519320

Contributors: Pusceddu, S.; Verzoni, E.; Prinzi, N.; Mennitto, A.; Femia, D.; Grassi, P.; Concas, L.; Vernieri, C.; Lo Russo, G.; Procopio, G.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted Agents

Oncology (Switzerland)
2017 | Journal article
EID:

2-s2.0-85013625460

Contributors: Grassi, P.; Doucet, L.; Giglione, P.; Grünwald, V.; Melichar, B.; Galli, L.; De Giorgi, U.; Sabbatini, R.; Ortega, C.; Santoni, M. et al.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

What advances have been made in immune-therapy for renal cell carcinoma?

Future Oncology
2017 | Journal article
EID:

2-s2.0-85015989777

Contributors: Verzoni, E.; Grassi, P.; Ratta, R.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Surgery of locally advanced and metastatic kidney cancer after tyrosine kinase inhibitors therapy: single institute experience.

2017-01 | Journal article
Contributors: De Gobbi A; Biasoni D; Catanzaro M; Nicolai N; Piva L; Stagni S; Torelli T; Procopio G; Verzoni E; Grassi P et al.
Source: Self-asserted source
Paolo Grassi via Europe PubMed Central

Adjuvant treatment for renal cell carcinoma: in the long run will we get the same answers?

Expert Review of Anticancer Therapy
2016 | Journal article
EID:

2-s2.0-84978976238

Contributors: Grassi, P.; Verzoni, E.; Procopio, G.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Cabozantinib in advanced renal cell carcinoma: A METEOR impact on clinical practice

Translational Andrology and Urology
2016 | Journal article
EID:

2-s2.0-85006256349

Contributors: Grassi, P.; Verzoni, E.; Mennitto, A.; Procopio, G.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Cabozantinib in the treatment of advanced renal cell carcinoma: Design, development, and potential place in the therapy

Drug Design, Development and Therapy
2016 | Journal article
EID:

2-s2.0-84978970987

Contributors: Grassi, P.; Verzoni, E.; Ratta, R.; Mennitto, A.; de Braud, F.; Procopio, G.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Clinical impact of Pancreatic metastases from renal cell carcinoma: A multicenter retrospective analysis

PLoS ONE
2016 | Journal article
EID:

2-s2.0-84963784539

Contributors: Grassi, P.; Doucet, L.; Giglione, P.; Grünwald, V.; Melichar, B.; Galli, L.; De Giorgi, U.; Sabbatini, R.; Ortega, C.; Santoni, M. et al.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Evolving treatment landscape in metastatic renal cell carcinoma: Where are we now?

Expert Review of Anticancer Therapy
2016 | Journal article
EID:

2-s2.0-84957647834

Contributors: Procopio, G.; Ratta, R.; Grassi, P.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Immunotherapy advances in uro-genital malignancies

Critical Reviews in Oncology/Hematology
2016 | Journal article
EID:

2-s2.0-84977602356

Contributors: Ratta, R.; Zappasodi, R.; Raggi, D.; Grassi, P.; Verzoni, E.; Necchi, A.; Di Nicola, M.; Salvioni, R.; de Braud, F.; Procopio, G.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Nivolumab in the treatment of advanced renal cell carcinoma: Clinical trial evidence and experience

Therapeutic Advances in Urology
2016 | Journal article
EID:

2-s2.0-84983775961

Contributors: Mennitto, A.; Grassi, P.; Ratta, R.; Verzoni, E.; Prisciandaro, M.; Procopio, G.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: A retrospective cohort study

Oncotarget
2016 | Journal article
EID:

2-s2.0-84982980466

Contributors: Verzoni, E.; de Giorgi, U.; Derosa, L.; Caffo, O.; Boccardo, F.; Facchini, G.; Porcu, L.; de Vincenzo, F.; Zaniboni, A.; Chiuri, V.E. et al.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors

Therapeutic Advances in Medical Oncology
2016 | Journal article
EID:

2-s2.0-84981298130

Contributors: Verzoni, E.; Grassi, P.; Ratta, R.; Niger, M.; De Braud, F.; Valdagni, R.; Procopio, G.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Treatment of elderly patients with metastatic renal cell carcinoma

Expert Review of Anticancer Therapy
2016 | Journal article
EID:

2-s2.0-84959544701

Contributors: Zanardi, E.; Grassi, P.; Cavo, A.; Verzoni, E.; Maggi, C.; De Braud, F.; Boccardo, F.; Procopio, G.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma

Therapeutic Advances in Urology
2015 | Journal article
EID:

2-s2.0-84930403925

Contributors: Zanardi, E.; Verzoni, E.; Grassi, P.; Necchi, A.; Giannatempo, P.; Raggi, D.; de Braud, F.; Procopio, G.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Clinical Outcomes of Metastatic Poor Prognosis Germ Cell Tumors: Current Perspective from a Referral Center

Clinical Genitourinary Cancer
2015 | Journal article
EID:

2-s2.0-84930573817

Contributors: Necchi, A.; Farè, E.; Vullo, S.L.; Giannatempo, P.; Raggi, D.; Nicolai, N.; Piva, L.; Biasoni, D.; Catanzaro, M.; Torelli, T. et al.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Everolimus and temsirolimus are not the same second-line in metastatic renal cell carcinoma. A systematic review and meta-analysis of literature data

Clinical Genitourinary Cancer
2015 | Journal article
EID:

2-s2.0-84924363912

Contributors: Iacovelli, R.; Santoni, M.; Verzoni, E.; Grassi, P.; Testa, I.; De Braud, F.; Cascinu, S.; Procopio, G.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Predicting Molecular Models: Where Are We Going?

EBioMedicine
2015 | Journal article
EID:

2-s2.0-84958903400

Contributors: Ratta, R.; Verzoni, E.; Grassi, P.; Niger, M.; Procopio, G.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors: Implications for clinical practice, trial design, and molecular interrogation

Urologic oncology
2015 | Journal article
EID:

2-s2.0-84982902972

Contributors: Raggi, D.; Mariani, L.; Giannatempo, P.; Lo Vullo, S.; Giardiello, D.; Nicolai, N.; Piva, L.; Biasoni, D.; Catanzaro, M.; Torelli, T. et al.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Safety of abiraterone acetate in castration-resistant prostate cancer patients with concomitant cardiovascular risk factors

American Journal of Clinical Oncology: Cancer Clinical Trials
2015 | Journal article
EID:

2-s2.0-84941880959

Contributors: Procopio, G.; Grassi, P.; Testa, I.; Verzoni, E.; Torri, V.; Salvioni, R.; Valdagni, R.; De Braud, F.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Sites of disease as predictors of outcome in metastatic renal cell carcinoma patients treated with first-line sunitinib or sorafenib

Therapeutic Advances in Urology
2015 | Journal article
EID:

2-s2.0-84925597560

Contributors: Grassi, P.; Verzoni, E.; Porcu, L.; Iacovelli, R.; de Braud, F.; Procopio, G.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Time from nephrectomy as a prognostic factor in metastatic renal cell carcinoma patients receiving targeted therapies: Overall results from a large cohort of patients

Oncology (Switzerland)
2015 | Journal article
EID:

2-s2.0-84924240427

Contributors: Procopio, G.; Testa, I.; Verzoni, E.; Iacovelli, R.; Grassi, P.; Galli, G.; De Braud, F.; Saravia, D.; Salvioni, R.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

TOKIO rationale and protocol: A phase II study to evaluate the activity and safety of third-line tyrosine kinase inhibitor after 2 tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma

Tumori
2015 | Journal article
EID:

2-s2.0-84949463893

Contributors: Verzoni, E.; Grassi, P.; Montone, R.; Galli, G.; Necchi, A.; Procopio, G.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Chronomodulated capecitabine and adjuvant radiation in intermediate-risk to high-risk rectal cancer: A phase II study

American Journal of Clinical Oncology: Cancer Clinical Trials
2014 | Journal article
EID:

2-s2.0-84916937480

Contributors: Bajetta, E.; Pietrantonio, F.; Buzzoni, R.; Ferrario, E.; Valvo, F.; Mariani, L.; Dotti, K.F.; Biondani, P.; Formisano, B.; Gevorgyan, A. et al.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Erratum: Safety profile and treatment response of everolimus in different solid tumors: An observational study (Future Oncology (2014) 10:9 (1611-1617))

Future Oncology
2014 | Journal article
EID:

2-s2.0-84907938478

Contributors: Verzoni, E.; Pusceddu, S.; Buzzoni, R.; Garanzini, E.; Damato, A.; Biondani, P.; Testa, I.; Grassi, P.; Bajetta, E.; De Braud, F. et al.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Rationale and protocol of RESORT, a randomized, open-label, multicenter phase II study to evaluate the efficacy of sorafenib in patients with advanced renal cell carcinoma after radical resection of the metastases

Tumori
2014 | Journal article
EID:

2-s2.0-84896958932

Contributors: Procopio, G.; Verzoni, E.; Biondani, P.; Grassi, P.; Testa, I.; Garanzini, E.; De Braud, F.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Rationale and protocol of SOAP: A phase II study to evaluate the efficacy of Sorafenib as second-line treatment after pazopanib in patients with advanced renal cell carcinoma

Tumori
2014 | Journal article
EID:

2-s2.0-84923286940

Contributors: Iacovelli, R.; Verzoni, E.; Grassi, P.; Farcomeni, A.; De Braud, F.; Procopio, G.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Response to targeted therapy in urachal adenocarcinoma

Rare Tumors
2014 | Journal article
EID:

2-s2.0-84919911350

Contributors: Testa, I.; Verzoni, E.; Grassi, P.; Colecchia, M.; Panzone, F.; Procopio, G.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Safety profile and treatment response of everolimus in different solid tumors: An observational study

Future Oncology
2014 | Journal article
EID:

2-s2.0-84906542656

Contributors: Verzoni, E.; Pusceddu, S.; Buzzoni, R.; Garanzini, E.; Damato, A.; Biondani, P.; Testa, I.; Grassi, P.; Bajetta, E.; Debraud, F. et al.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Sequential tyrosine kinase inhibitors (TKIs) in metastatic renal cell carcinoma: Results from a large cohort of patients

Anticancer Research
2014 | Journal article
EID:

2-s2.0-84902959014

Contributors: Biondani, P.; Verzoni, E.; Torri, V.; Porcu, L.; Grassi, P.; Testa, I.; De Braud, F.; Procopio, G.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Targeted therapies in advanced renal cell carcinoma: The role of metastatic sites as a prognostic factor

Future Oncology
2014 | Journal article
EID:

2-s2.0-84905246145

Contributors: Grassi, P.; Verzoni, E.; Porcu, L.; Testa, I.; Iacovelli, R.; Torri, V.; Braud, F.D.; Procopio, G.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Targeted treatments in advanced renal cell carcinoma: Focus on Axitinib

Pharmacogenomics and Personalized Medicine
2014 | Journal article
EID:

2-s2.0-84898745413

Contributors: Verzoni, E.; Grassi, P.; Testa, I.; Iacovelli, R.; Biondani, P.; Garanzini, E.; De Braud, F.; Procopio, G.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Treatment of collecting duct carcinoma: Current status and future perspectives

Anticancer Research
2014 | Journal article
EID:

2-s2.0-84897029961

Contributors: Procopio, G.; Testa, I.; Iacovelli, R.; Grassi, P.; Verzoni, E.; Garanzini, E.; Colecchia, M.; Torelli, T.; De Braud, F.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Sequential Tyrosine Kinase Inhibitors (TKIs) in metastatic renal cell carcinoma: results from a large cohort of patients.

2014-05 | Journal article
Contributors: Biondani P; Verzoni E; Torri V; Porcu L; Grassi P; Testa I; DE Braud F; Procopio G
Source: Self-asserted source
Paolo Grassi via Europe PubMed Central

Treatment of collecting duct carcinoma: current status and future perspectives.

2014-02 | Journal article
Contributors: Procopio G; Testa I; Iacovelli R; Grassi P; Verzoni E; Garanzini E; Colecchia M; Torelli T; De Braud F
Source: Self-asserted source
Paolo Grassi via Europe PubMed Central

Patient approach in advanced/metastatic renal cell carcinoma: Focus on the elderly population and treatment-related toxicity

Future Oncology
2013 | Journal article
EID:

2-s2.0-84887309872

Contributors: Verzoni, E.; De Braud, F.; Fabiani, F.; Grassi, P.; Testa, I.; Procopio, G.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Prognostic role of pancreatic metastases from renal cell carcinoma: Results from an Italian center

Clinical Genitourinary Cancer
2013 | Journal article
EID:

2-s2.0-84888009026

Contributors: Grassi, P.; Verzoni, E.; Mariani, L.; De Braud, F.; Coppa, J.; Mazzaferro, V.; Procopio, G.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Safety and efficacy of oral vinorelbine and capecitabine combination for metastatic breast cancer

Journal of Chemotherapy
2011 | Journal article
EID:

2-s2.0-80052778712

Contributors: di Seri, M.; de Sanctis, R.; Quadrini, S.; Adua, D.; Stumbo, L.; del Signore, E.; Gori, B.; Grassi, P.; Basile, M.L.; Longo, F.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Weekly combination of non-pegylated liposomal doxorubicin and taxane in first-line breast cancer: wALT trial (phase I-II)

Annals of Oncology
2011 | Journal article
EID:

2-s2.0-79251576825

Contributors: Rosati, M.S.; Raimondi, C.; Baciarello, G.; Grassi, P.; Giovannoni, S.; Petrelli, E.; Basile, M.L.; Girolami, M.; di Seri, M.; Frati, L.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier

Antiangiogenic metronomic chemotherapy and hyperthermia in the palliation of advanced cancer: Original article

European Journal of Cancer Care
2007 | Journal article
EID:

2-s2.0-34248562373

Contributors: Franchi, F.; Grassi, P.; Ferro, D.; Pigliucci, G.; De Chicchis, M.; Castigliani, G.; Pastore, C.; Seminara, P.
Source: Self-asserted source
Paolo Grassi via Scopus - Elsevier